209
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Function and mechanism exploration of zinc finger protein 64 in lung adenocarcinoma cell growth and metastasis

, , &
Pages 457-465 | Received 11 May 2020, Accepted 02 Sep 2020, Published online: 15 Oct 2020

References

  • Hong QY, Wu GM, Qian GS, et al.; Lung Cancer Group of Chinese Thoracic Society; Chinese Alliance Against Lung Cancer. Prevention and management of lung cancer in China. Cancer. 2015;121 Suppl 17:3080–3088.
  • Alam H, Li N, Dhar SS, et al. HP1γ promotes lung adenocarcinoma by downregulating the transcription-repressive regulators NCOR2 and ZBTB7A . Cancer Research. 2018;78:3834–3848.
  • Sun X, Jia M, Sun W, et al. Functional role of RBM10 in lung adenocarcinoma proliferation. Int J Oncol. 2019;54:467–478.
  • Jen J, Wang YC. Zinc finger proteins in cancer progression. J Biomed Sci. 2016;23:53.
  • Xiao Y, Xiang T, Luo X, et al. Zinc-finger protein 545 inhibits cell proliferation as a tumor suppressor through inducing apoptosis and is disrupted by promoter methylation in breast cancer. PloS One. 2014;9:e110990.
  • Li SY, An P, Cai HY, et al. Proteomic analysis of differentially expressed proteins involving in liver metastasis of human colorectal carcinoma. Hepatobiliary Pancreat Dis Int. 2010;9:149–153.
  • Kontomanolis EN, Kalagasidou S, Pouliliou S, et al. The notch pathway in breast cancer progression. ScientificWorldJournal. 2018;2018:2415489.
  • Li L, Tang P, Li S, et al. Notch signaling pathway networks in cancer metastasis: a new target for cancer therapy. Med Oncol. 2017;34:180.
  • Wu WK, Wang XJ, Cheng AS, et al. Dysregulation and crosstalk of cellular signaling pathways in colon carcinogenesis. Crit Rev Oncol Hematol. 2013;86:251–277.
  • Serafin V, Persano L, Moserle L, et al. Notch3 signalling promotes tumour growth in colorectal cancer. J Pathol. 2011;224:448–460.
  • Carvalho FL, Simons BW, Eberhart CG, et al. Notch signaling in prostate cancer: a moving target. Prostate. 2014;74:933–945.
  • Hassan KA, Wang L, Korkaya H, et al. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma. Clin Cancer Res. 2013;19:1972–1980.
  • Pei L, He X, Li S, et al. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer. Int J Oncol. 2018;53:961–972.
  • Sakamoto K, Tamamura Y, Katsube K-i, et al. Zfp64 participates in Notch signaling and regulates differentiation in mesenchymal cells. J Cell Sci. 2008;121:1613–1623.
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego, Calif). 2001;25:402–408.
  • Jin J, Wang T, Wang Y, et al. SRC3 expressed in BMSCs promotes growth and migration of multiple myeloma cells by regulating the expression of Cx43. Int J Oncol. 2017;51:1694–1704.
  • Tong L, Liu J, Yan W, et al. RDM1 plays an oncogenic role in human lung adenocarcinoma cells. Sci Rep. 2018;8:11525.
  • Pi B, He X, Ruan Y, et al. Genome-wide analysis and stress-responsive expression of CCCH zinc finger family genes in Brassica rapa. BMC Plant Biol. 2018;18:373.
  • Laity JH, Lee BM, Wright PE. Zinc finger proteins: new insights into structural and functional diversity. Curr Opin Struct Biol. 2001;11:39–46.
  • Razin SV, Borunova VV, Maksimenko OG, et al. Cys2His2 zinc finger protein family: classification, functions, and major members. Biochemistry (Mosc). 2012;77:217–226.
  • Sugai T, Habano W, Takagi R, et al. Analysis of molecular alterations in laterally spreading tumors of the colorectum. J Gastroenterol. 2017;52:715–723.
  • Habano W, Sugai T, Jiao YF, et al. Novel approach for detecting global epigenetic alterations associated with tumor cell aneuploidy. Int J Cancer. 2007;121:1487–1493.
  • Serrano-Gomez SJ, Maziveyi M, Alahari SK. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications. Mol Cancer. 2016;15:18.
  • Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–196.
  • Suarez-Carmona M, Lesage J, Cataldo D, et al. EMT and inflammation: inseparable actors of cancer progression. Mol Oncol. 2017;11:805–823.
  • Zhou J, Tao D, Xu Q, et al. Expression of E-cadherin and vimentin in oral squamous cell carcinoma. Int J Clin Exp Path. 2015;8:3150–3154.
  • Liu CY, Lin HH, Tang MJ, et al. Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation. Oncotarget. 2015;6:15966–15983.
  • Dong Q, Zhu X, Dai C, et al. Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin. Oncotarget. 2016;7:12997–13012.
  • Takebe N, Miele L, Harris PJ, et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update. Nat Rev Clin Oncol. 2015;12:445–464.
  • Zanotti S, Canalis E. Notch signaling and the skeleton. Endocr Rev. 2016;37:223–253.
  • Yamamoto S, Schulze KL, Bellen HJ. Introduction to Notch signaling. Methods Mol Biol. 2014;1187:1–14.
  • Li X, Liu F, Zhang X, et al. Notch-Hes-1 axis controls TLR7-mediated autophagic death of macrophage via induction of P62 in mice with lupus. Cell Death Dis. 2016;7:e2341.
  • Zheng Q, Qin H, Zhang H, et al. Notch signaling inhibits growth of the human lung adenocarcinoma cell line A549. Oncol Rep. 2007;17:847–852.
  • South AP, Cho RJ, Aster JC. The double-edged sword of Notch signaling in cancer. Semin Cell Dev Biol. 2012;23:458–464.
  • Krop I, Demuth T, Guthrie T, et al. Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors. J Clin Oncol. 2012;30:2307–2313.
  • Cook N, Basu B, Smith DM, et al. A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma. Br J Cancer. 2018;118:793–801.
  • Hoffman LM, Fouladi M, Olson J, et al. Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study. Childs Nerv Syst. 2015;31:1283–1289.
  • Piha-Paul SA, Munster PN, Hollebecque A, et al. Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumours. Eur J Cancer. 2015;51:1865–1873.
  • Guo L, Zhang T, Xiong Y, et al. Roles of NOTCH1 as a therapeutic target and a biomarker for lung cancer: controversies and perspectives. Dis Markers. 2015;2015:520590.
  • Baumgart A, Seidl S, Vlachou P, et al. ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancer. Cancer Res. 2010;70:5368–5378.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.